Articoli con mandati relativi all'accesso pubblico - Sarah FortuneUlteriori informazioni
TotaleNIHGatesDoDHHMIDoris Duke Charitable FoundationNSFWellcomeMRCNHMRCNSFCEuropean CommissionCIHRNational Research Foundation, SingaporeEMBLDOESNSFNOAAARCFWOFRQSNSERCCASHRBDBTNWOA*StarVersus Arthritis, UKCancer Research UKESRCNIHRNRFANRGovernment of SpainGoverno ItalianoDamon Runyon Cancer Research FoundationMQ Mental Health ResearchHealth and Care Research Wales
Non disponibili pubblicamente: 3
Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria
JC Kester, SM Fortune
Critical reviews in biochemistry and molecular biology 49 (2), 91-101, 2014
Mandati: US National Institutes of Health, Doris Duke Charitable Foundation
DNA Replication Fidelity in the Mycobacterium tuberculosis Complex
DF Warner, JM Rock, SM Fortune, V Mizrahi
Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in …, 2017
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, National …
exposure among male South African gold miners
LRL Davies, MT Smith, D Cizmeci, S Fischinger, JSL Lee, LL Lu, ...
infection 2, 4, 2023
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health, Doris …
Disponibili pubblicamente: 136
SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues
CGK Ziegler, SJ Allon, SK Nyquist, IM Mbano, VN Miao, CN Tzouanas, ...
Cell 181 (5), 1016-1035. e19, 2020
Mandati: US National Science Foundation, Bill & Melinda Gates Foundation, US …
Definitions and guidelines for research on antibiotic persistence
NQ Balaban, S Helaine, K Lewis, M Ackermann, B Aldridge, DI Andersson, ...
Nature Reviews Microbiology 17 (7), 441-448, 2019
Mandati: US National Institutes of Health, European Molecular Biology Laboratory, UK …
Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput
TM Gierahn, MH Wadsworth, TK Hughes, BD Bryson, A Butler, R Satija, ...
Nature methods 14 (4), 395-398, 2017
Mandati: Bill & Melinda Gates Foundation, US Department of Defense, US National …
Beyond binding: antibody effector functions in infectious diseases
LL Lu, TJ Suscovich, SM Fortune, G Alter
Nature Reviews Immunology 18 (1), 46-61, 2018
Mandati: US Department of Defense, US National Institutes of Health
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis
MA DeJesus, ER Gerrick, W Xu, SW Park, JE Long, CC Boutte, EJ Rubin, ...
MBio 8 (1), 10.1128/mbio. 02133-16, 2017
Mandati: US National Science Foundation, US National Institutes of Health
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
PL Lin, CB Ford, MT Coleman, AJ Myers, R Gawande, T Ioerger, ...
Nature medicine 20 (1), 75-79, 2014
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
A functional role for antibodies in tuberculosis
LL Lu, AW Chung, TR Rosebrock, M Ghebremichael, WH Yu, PS Grace, ...
Cell 167 (2), 433-443. e14, 2016
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Doris …
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection
CB Ford, PL Lin, MR Chase, RR Shah, O Iartchouk, J Galagan, ...
Nature genetics 43 (5), 482-486, 2011
Mandati: US National Institutes of Health
Heterogeneity in tuberculosis
AM Cadena, SM Fortune, JAL Flynn
Nature Reviews Immunology 17 (11), 691-702, 2017
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health
Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility
BB Aldridge, M Fernandez-Suarez, D Heller, V Ambravaneswaran, ...
Science 335 (6064), 100-104, 2012
Mandati: US National Institutes of Health, Doris Duke Charitable Foundation
Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform
JM Rock, FF Hopkins, A Chavez, M Diallo, MR Chase, ER Gerrick, ...
Nature microbiology 2 (4), 1-9, 2017
Mandati: US National Institutes of Health, Doris Duke Charitable Foundation
Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair
M Divangahi, M Chen, H Gan, D Desjardins, TT Hickman, DM Lee, ...
Nature immunology 10 (8), 899-906, 2009
Mandati: US National Institutes of Health, Fonds de recherche du Québec - Santé
Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition
MS Siegrist, M Unnikrishnan, MJ McConnell, M Borowsky, TY Cheng, ...
Proceedings of the National Academy of Sciences 106 (44), 18792-18797, 2009
Mandati: US National Institutes of Health
NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis
AK Pandey, Y Yang, Z Jiang, SM Fortune, F Coulombe, MA Behr, ...
PLoS pathogens 5 (7), e1000500, 2009
Mandati: US National Institutes of Health
Variability in tuberculosis granuloma T cell responses exists, but a balance of pro-and anti-inflammatory cytokines is associated with sterilization
HP Gideon, JY Phuah, AJ Myers, BD Bryson, MA Rodgers, MT Coleman, ...
PLoS pathogens 11 (1), e1004603, 2015
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health
Efferocytosis is an innate antibacterial mechanism
CJ Martin, MG Booty, TR Rosebrock, C Nunes-Alves, DM Desjardins, ...
Cell host & microbe 12 (3), 289-300, 2012
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software